CISD

Centro internazionale studi diabete
dal 1983

Pubblicazioni

Elenco di alcune pubblicazioni dell'ultimo quinquennio in cui il CISD ha dato il proprio contributo (da Pubmed)

AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvest. Leotta S, Poidomani M, Mauro E, Spadaro A, Marturano E, Milone G. Bone Marrow Transplant. 2010 May 3, in press.

No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG, Cappa M, Ghirlanda G, Pozzilli P; IMDIAB Group. Diabetes Care. 2010 Sep;33(9):1962-3.

Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Bruno G, Maule M, Merletti F, Novelli G, Falorni A, Iannilli A, Iughetti L, Altobelli E, d'Annunzio G, Piffer S, Pozzilli P, Iafusco D, Songini M, Roncarolo F, Toni S, Carle F, Cherubini V; RIDI Study Group. Diabetes. 2010 Sep;59(9):2281-7.

Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). Zampetti S, Spoletini M, Petrone A, Capizzi M, Arpi ML, Tiberti C, Di Pietro S, Bosi E, Pozzilli P, Giorgino F, Buzzetti R; Nirad Study Group. Diabet Med. 2010 Jun;27(6):701-4.

The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach. Pozzilli P, Leslie RD, Chan J, De Fronzo R, Monnier L, Raz I, Del Prato S. Diabetes Metab Res Rev. 2010 May;26(4):239-44.

Computer use, free time activities and metabolic control in patients with type 1 diabetes. Benevento D, Bizzarri C, Pitocco D, Crinò A, Moretti C, Spera S, Tubili C, Costanza F, Maurizi A, Cipolloni L, Cappa M, Pozzilli P; IMDIAB Group. Diabetes Res Clin Pract. 2010 Jun;88(3):e32-4.

Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon. Napoli N, Mottini G, Arigliani M, Creta A, Giua R, Incammisa A, Carotti S, Sihom F, Yimagou I, Alombah R, Mbanya JC, Pozzilli P. Diabetes Metab Res Rev. 2010 Jan;26(1):10-2.

Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Cardwell CR, Stene LC, Joner G, Davis EA, Cinek O, Rosenbauer J, Ludvigsson J, Castell C, Svensson J, Goldacre MJ, Waldhoer T, Polanska J, Gimeno SG, Chuang LM, Parslow RC, Wadsworth EJ, Chetwynd A, Pozzilli P, Brigis G, Urbonaite B, Sipetić S, Schober E, Ionescu-Tirgoviste C, de Beaufort CE, Stoyanov D, Buschard K, Patterson CC. Diabetologia. 2010 Apr;53(4):641-51.

Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women. Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R. Bone. 2010 Apr;46(4):1063-7.

Review of clinical trials: update on oral insulin spray formulation. Pozzilli P, Raskin P, Parkin CG. Diabetes Obes Metab. 2010 Feb;12(2):91-6.

Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies. Cardwell CR, Stene LC, Joner G, Bulsara MK, Cinek O, Rosenbauer J, Ludvigsson J, Jané M, Svensson J, Goldacre MJ, Waldhoer T, Jarosz-Chobot P, Gimeno SG, Chuang LM, Parslow RC, Wadsworth EJ, Chetwynd A, Pozzilli P, Brigis G, Urbonaite B, Sipetic S, Schober E, Devoti G, Ionescu-Tirgoviste C, de Beaufort CE, Stoyanov D, Buschard K, Patterson CC. Diabetes. 2010 Feb;59(2):486-94.

Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine. Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P, Santeusanio F. Nutr Metab Cardiovasc Dis. 2010 Sep;20(7):519-26.

Challenges in developing endpoints for type 1 diabetes intervention studies. Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P, Little R, Schloot NC, Leslie RD, Skyler JS, Palmer JP; D-Cure Workshop. Diabetes Metab Res Rev. 2009 Nov;25(8):694-704.

Beta-cell protection and therapy for latent autoimmune diabetes in adults. Cernea S, Buzzetti R, Pozzilli P. Diabetes Care. 2009 Nov;32 Suppl 2:S246-52.

Physical exercise, public health and quality of life in diabetes. Fallucca F, Pozzilli P. Diabetes Metab Res Rev. 2009 Sep;25 Suppl 1:S1-3.

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team. Lancet. 2009 Jun 20;373(9681):2125-35.

New prospects for immunotherapy at diagnosis of type 1 diabetes. Pozzilli P, Leslie RD. Diabetes Metab Res Rev. 2009 May;25(4):299-301.

Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Pozzilli P, Guglielmi C. Endocr Dev. 2009;14:151-66.

Metabolic syndrome and autoimmune diabetes: action LADA 3. Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R, de Leiva A, Pozzilli P, Leslie RD; Action LADA Group. Diabetes Care. 2009 Jan;32(1):160-4.

Self glucose monitoring and physical exercise in diabetes. Pugliese G, Zanuso S, Alessi E, Simonelli P, Fallucca S, Fallucca F, Balducci S. Diabetes Metab Res Rev. 2009 Sep;25 Suppl 1:S11-7.

Physical activity/exercise training in type 2 diabetes. The role of the Italian Diabetes and Exercise Study. Balducci S, Zanuso S, Fernando F, Fallucca S, Fallucca F, Pugliese G; Italian Diabetes Exercise Study (IDES) Group. Diabetes Metab Res Rev. 2009 Sep;25 Suppl 1:S29-33.

Hypertensive disorders in normal/over-weight and obese type 2 diabetic pregnant women. Colatrella A, Braucci S, Festa C, Bianchi P, Fallucca F, Mattei L, Trappolini M, Napoli A. Exp Clin Endocrinol Diabetes. 2009 Sep;117(8):373-7.

Visual evoked potentials in infants of diabetic mothers: relations to clinical and metabolic status during pregnancy and delivery. Brinciotti M, Matricardi M, Colatrella A, Torcia F, Fallucca F, Napoli A. Clin Neurophysiol. 2009 Mar;120(3):563-8.

Efficacy of external conventional radiotherapy in short and long term control of Acromegaly; a comparison with stereotactic irradiation. Mecca N, Barbarulo F, Mercuri V, D'Amico T, Minniti G, Tamburrano G, Pietrobono D, Carocci S, Gargiulo P. Clin Ter. 2009 Jul-Aug;160(4):277-282.

Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. Lombardi G, Minuto F, Tamburrano G, Ambrosio MR, Arnaldi G, Arosio M, Chiarini V, Cozzi R, Grottoli S, Mantero F, Bogazzi F, Terzolo M, Tita P, Boscani PF, Colao A. J Endocrinol Invest. 2009 Mar;32(3):202-9.

Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, Vitali L, Bulotta A, Nicoziani P, Coronel G; QuoLITy Study Group. Nutr Metab Cardiovasc Dis. 2009 Jan;19(1):45-53.

New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes. Cernea S, Pozzilli P. Diabet Med. 2008 Nov;25(11):1259-67.

A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years. Pronina EA, Petraikina EE, Antsiferov MB, Duchareva OV, Petrone A, Buzzetti R, Pozzilli P. Diabet Med. 2008 Aug;25(8):956-9.

Endothelial progenitor cells and their potential therapeutic applications. Khoo CP, Pozzilli P, Alison MR. Regen Med. 2008 Nov;3(6):863-76.

Antinuclear antibodies prevalence in Filipinos migrated to Italy. Cacciapaglia F, Arcarese L, Rigon A, Vadacca M, Valorani MG, Pozzilli P, Afeltra A. Eur Rev Med Pharmacol Sci. 2008 Jul-Aug;12(4):267-70.

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group. Diabetes Care. 2008 Oct;31(10):1966-71.

Diabetes classification: grey zones, sound and smoke: Action LADA 1. Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum W, Williams R, Pozzilli P. Diabetes Metab Res Rev. 2008 Oct;24(7):511-9.

Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P, Buzzetti R, Erlich HA. Hum Immunol. 2008 Apr-May;69(4-5):291-300.

Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, Parslow RC, Pozzilli P, Brigis G, Stoyanov D, Urbonaite B, Sipetić S, Schober E, Ionescu-Tirgoviste C, Devoti G, de Beaufort CE, Buschard K, Patterson CC. Diabetologia. 2008 May;51(5):726-35.

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group. Diabetes Care. 2008 Jun;31(6):1214-8.

Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function. Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. Horm Metab Res. 2008 Jan;40(1):66-8.

Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N, Buzzetti R, Davies H, Leslie D, Williams R; Action LADA Group. Diabetes Care. 2008 Mar;31(3):439-41.

The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group. Diabetes Care. 2008 Mar;31(3):534-8.

Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy. Chianelli M, Parisella MG, Visalli N, Mather SJ, D'Alessandria C, Pozzilli P, Signore A; IMDIAB study group. Diabetes Metab Res Rev. 2008 Feb;24(2):115-22.

The Italian Diabetes and Exercise Study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome. Balducci S, Zanuso S, Massarini M, Corigliano G, Nicolucci A, Missori S, Cavallo S, Cardelli P, Alessi E, Pugliese G, Fallucca F; Italian Diabetes Exercise Study (IDES) Group. Nutr Metab Cardiovasc Dis. 2008 Nov;18(9):585-95.

Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths. Pozzilli P, Guglielmi C, Pronina E, Petraikina E. Pediatr Diabetes. 2007 Dec;8 Suppl 9:88-95.

Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis. Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D, Pozzilli P, Buzzetti R; IMDIAB Group. Diabet Med. 2007 Dec;24(12):1487-90.

Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). Locatelli M, Buzzetti R, Galgani A, Montemari AL, Khazrai M, Petrone A, Visalli N, Meschi F, Minicucci L, Lorini R, Cristaldi A, Valorani MG, Bottazzo GF, Pozzilli P; DIABFIN Study Group. Diabet Med. 2007 Aug;24(8):916-9.

Immuno-intervention and preservation of beta-cell function in type 1 diabetes. Pozzilli P. Diabetes Metab Res Rev. 2007 May;23(4):255-6.

A new expression of diabetes: double diabetes. Pozzilli P, Buzzetti R. Trends Endocrinol Metab. 2007 Mar;18(2):52-7.

Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P; IMDIAB Group. Diabetes Metab Res Rev. 2007 Mar;23(3):211-4.

Implementing a guideline for the treatment of type 2 diabetics: results of a cluster-randomized controlled trial (C-RCT). Perria C, Mandolini D, Guerrera C, Jefferson T, Billi P, Calzini V, Fiorillo A, Grasso G, Leotta S, Marrocco W, Suraci C, Pasquarella A. BMC Health Serv Res. 2007 Jun 4;7:79.

QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA. Santini V, Ciampittiello G, Gigli F, Bracaglia D, Baroni A, Cicconetti E, Verri C, Gambardella S, Frontoni S. Nutr Metab Cardiovasc Dis. 2007 Dec;17(10):712-8.

Effects of maternal diabetes on visual evoked potentials and early psychomotor development of the offspring. Brinciotti M, Matricardi M, Colatrella A, Torcia F, Fallucca F, Napoli A. Diabetes Care. 2007 Dec;30(12):e128.

The loss of entropy circadian rhythm in sinusal R-R intervals of type 1 diabetic pregnant women suggests an indeterministic chaos in cardiac pacing (minimum delirium cordis syndrome). A newly identifiable type of silent cardiac dysautonomia? Cugini P, Curione M, Castro C, Napoli A, Francia P, Colatrella A, Di Bona S, Cammarota C, Cardarelli G, Amato S, Fallucca F. Acta Cardiol. 2007 Jun;62(3):257-64.

Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy. Caliumi C, Balducci S, Petramala L, Cotesta D, Zinnamosca L, Cianci R, Di Donato D, Vingolo EM, Fallucca F, Letizia C. Minerva Endocrinol. 2007 Jun;32(2):73-8.

Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis: response to Snowling and Hopkins. Balducci S, Alessi E, Cardelli P, Cavallo S, Fallucca F, Pugliese G. Diabetes Care. 2007 Apr;30(4):e25; author reply e26.

Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study. Ronchi CL, Boschetti M, Degli Uberti EC, Mariotti S, Grottoli S, Loli P, Lombardi G, Tamburrano G, Arvigo M, Angeletti G, Boscani PF, Beck-Peccoz P, Arosio M; Italian Multicenter Autogel Study Group in Acromegaly. Clin Endocrinol (Oxf). 2007 Oct;67(4):512-9.

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabaté MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wémeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montañana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A. J Clin Endocrinol Metab. 2007 May;92(5):1891-6. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes. Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P. Horm Metab Res. 2006 Oct;38(10):668-72.

Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RF, Chen L, Warnock GL. Cell Transplant. 2006;15(5):399-410.

The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. Diabet Med. 2006 Aug;23(8):920-3.

Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Prisco F, Picardi A, Iafusco D, Lorini R, Minicucci L, Martinucci ME, Toni S, Cerutti F, Rabbone I, Buzzetti R, Crino A, Pozzilli P. Pediatr Diabetes. 2006 Aug;7(4):223-8.

Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Riccardi G, Travaglini P, Morenghi E, Bosi E, Pozzilli P. Eur J Endocrinol. 2006 Mar;154(3):441-7.

Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. Leslie RD, Williams R, Pozzilli P. J Clin Endocrinol Metab. 2006 May;91(5):1654-9.

Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy. Fallucca F, Dalfrà MG, Sciullo E, Masin M, Buongiorno AM, Napoli A, Fedele D, Lapolla A. Metabolism. 2006 Nov;55(11):1451-6.

Use of repaglinide during the first weeks of pregnancy in two type 2 diabetic women. Napoli A, Ciampa F, Colatrella A, Fallucca F. Diabetes Care. 2006 Oct;29(10):2326-7.

Exercise training can modify the natural history of diabetic peripheral neuropathy. Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, Fallucca F. J Diabetes Complications. 2006 Jul-Aug;20(4):216-23.

Clinical characterization of familial isolated pituitary adenomas. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wémeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A. J Clin Endocrinol Metab. 2006 Sep;91(9):3316-23.